Cargando…

Concise evaluation and therapeutic guidelines for severe periodontitis: A public health perspective

The main goal of periodontology is to prevent and arrest gingivitis and periodontitis to avoid tooth loss and focal infection of periodontal origin. Periodontal scaling or flap surgery of moderate‐to‐severe periodontitis have shortcomings, most likely because removal of herpesviruses and bacterial p...

Descripción completa

Detalles Bibliográficos
Autor principal: Slots, Jørgen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9804657/
https://www.ncbi.nlm.nih.gov/pubmed/35913496
http://dx.doi.org/10.1111/prd.12463
_version_ 1784862159612674048
author Slots, Jørgen
author_facet Slots, Jørgen
author_sort Slots, Jørgen
collection PubMed
description The main goal of periodontology is to prevent and arrest gingivitis and periodontitis to avoid tooth loss and focal infection of periodontal origin. Periodontal scaling or flap surgery of moderate‐to‐severe periodontitis have shortcomings, most likely because removal of herpesviruses and bacterial pathogens in deep periodontal lesions and the adjacent inflamed gingiva requires systemic antimicrobial treatment (or gingivectomy). Valacyclovir (1000 mg twice daily on day 1, and 500 mg twice daily on day 2 and on day 3) is a potent anti‐herpesvirus agent. Antibiotic combinations against bacterial pathogens include amoxicillin‐metronidazole (250 mg of each, thrice daily for 4 days; for systemically healthy adults) and ciprofloxacin‐metronidazole (500 mg of each, twice daily for 4 days; for immunosuppressed individuals and patients exposed to contaminated water and poor sanitation). Supportive antiseptic treatment may consist of 0.1%‐0.2% sodium hypochlorite (regular household bleach) as cooling spray in ultrasonic scalers, flosser fluid in oral irrigators, and mouthrinse in patient self‐care. The anti‐infective treatment described here helps control cases of severe periodontitis and constitutes an exceedingly inexpensive alternative to conventional (mechanical) periodontal therapy.
format Online
Article
Text
id pubmed-9804657
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-98046572023-01-06 Concise evaluation and therapeutic guidelines for severe periodontitis: A public health perspective Slots, Jørgen Periodontol 2000 Commentary The main goal of periodontology is to prevent and arrest gingivitis and periodontitis to avoid tooth loss and focal infection of periodontal origin. Periodontal scaling or flap surgery of moderate‐to‐severe periodontitis have shortcomings, most likely because removal of herpesviruses and bacterial pathogens in deep periodontal lesions and the adjacent inflamed gingiva requires systemic antimicrobial treatment (or gingivectomy). Valacyclovir (1000 mg twice daily on day 1, and 500 mg twice daily on day 2 and on day 3) is a potent anti‐herpesvirus agent. Antibiotic combinations against bacterial pathogens include amoxicillin‐metronidazole (250 mg of each, thrice daily for 4 days; for systemically healthy adults) and ciprofloxacin‐metronidazole (500 mg of each, twice daily for 4 days; for immunosuppressed individuals and patients exposed to contaminated water and poor sanitation). Supportive antiseptic treatment may consist of 0.1%‐0.2% sodium hypochlorite (regular household bleach) as cooling spray in ultrasonic scalers, flosser fluid in oral irrigators, and mouthrinse in patient self‐care. The anti‐infective treatment described here helps control cases of severe periodontitis and constitutes an exceedingly inexpensive alternative to conventional (mechanical) periodontal therapy. John Wiley and Sons Inc. 2022-08-01 2022-10 /pmc/articles/PMC9804657/ /pubmed/35913496 http://dx.doi.org/10.1111/prd.12463 Text en © 2022 The Author. Periodontology 2000 published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Commentary
Slots, Jørgen
Concise evaluation and therapeutic guidelines for severe periodontitis: A public health perspective
title Concise evaluation and therapeutic guidelines for severe periodontitis: A public health perspective
title_full Concise evaluation and therapeutic guidelines for severe periodontitis: A public health perspective
title_fullStr Concise evaluation and therapeutic guidelines for severe periodontitis: A public health perspective
title_full_unstemmed Concise evaluation and therapeutic guidelines for severe periodontitis: A public health perspective
title_short Concise evaluation and therapeutic guidelines for severe periodontitis: A public health perspective
title_sort concise evaluation and therapeutic guidelines for severe periodontitis: a public health perspective
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9804657/
https://www.ncbi.nlm.nih.gov/pubmed/35913496
http://dx.doi.org/10.1111/prd.12463
work_keys_str_mv AT slotsjørgen conciseevaluationandtherapeuticguidelinesforsevereperiodontitisapublichealthperspective